How can you ensure your plasmid products are fit-for-purpose?
In today's evolving advanced therapies ecosystem, plasmid DNA retains its common role as a critical starting material for a range of advanced therapeutic modalities, laying the foundations for mRNA, cell, and gene therapy production.
In this bite-sized 30-minute webinar, our subject matter experts will cover common issues and quality control (QC) considerations from a manufacturing perspective.
You will learn:
- Current industry standards for plasmid DNA manufacturing quality and testing
- Latest technologies and platform enhancements to streamline production with a focus on product quality
- Key challenges in critical starting materials manufacture and what you need to know to safeguard development and manufacture
Linearized Plasmid for Your mRNA Therapy
Available stand-alone or as a modular add-on to phase-appropriate plasmid production, leverage a robust plug-and-play screening toolbox to manage long polyA sequences prone to truncation, and safeguard your supply.
Find Out More
Webinar Presenters
Andrew Frazer, PhD
Associate Director, Scientific Solutions, Gene Therapy CDMO Services
Charles River
Lauren R Salvitti, PhD
Research and Development Manager, Microbial Solutions
Charles River
Shane Lovatt
QC Manager - Analytics
Charles River
Jon Brook-Jones
QC Principal Scientist - Analytics
Charles River
Charlotte Baker
Editor
BioInsights